Trials / Completed
CompletedNCT03429192
A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,653 (actual)
- Sponsor
- Tianjin Chest Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases
Detailed description
A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgery | Surgeries plus dissection of lymph nodes |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2018-03-30
- Completion
- 2018-03-30
- First posted
- 2018-02-12
- Last updated
- 2018-05-21
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03429192. Inclusion in this directory is not an endorsement.